The 5th New York Health Forum was held at the
Yale Club of New York City on Thursday, March 31st of 2016. It provided a
setting for stimulating informative discussions on topics such as investment
trends, landscapes, and risks in the current healthcare industry. The central
theme for this forum was “Key Trends in US Biopharma/Medtech Investing”. Over
70 guests including investors, biopharma and medtech representatives, and
healthcare professionals attended the forum to provide opportunities, share
information, and discuss ideas.
The program began with a luncheon and an
opportunity for the attendees to associate and connect with one another.
Following this was an opening remark delivered by DoHyun Cho, PhD, CEO and
President of W Medical Strategy Group and the Chairman of the NYHF. A total of
three active sessions were held followed by a Q&A session, creating a
moment for the audience to engage with the panelists and voice their opinions
as well.
The first session titled “Biopharma/ Medtech
Funding Trends and Investment Landscape” was moderated by Joseph P. McMenamin
MD, JD and FCLM and paneled by Sean Drake, the Managing Director at Stony
Lonesome Group LLC, and Katya Hancock, the Director of Strategic Partnerships
at StartUp Health. During this session, the panelists examined the current
state of biopharma/medtech financing and the factors that have led to the
current financing environment.
The second session titled “The Key Factors to
Raising Capital: What Will Attract Investors?” was moderated by Kimberly Ha and
paneled by Norman Yun, Managing Director at H. C. Wainwright & Co., and
Vincent Liu, PhD, Senior Advisor for Shanghai Fosun pharmaceutical group. At
this session, discussion took place on the trends and dynamics of current
biopharma/ medtech industry investment.
The final session was moderated by Tony Chen,
CEO of PrimeVax Immuno-Oncology Inc. and titled “New Breed of Contributors:
Alternative Biopharma/Medtech Financing”. Panelists included Frank Borchetta,
CEO & Co-Founder of Repairogen Corporation, Imran Babar, PhD, Senior
Associate at OrbiMed LLC, and Karen Carr, Regional Development Officer at
Gateway for Cancer Research. The panelists discussed the new trends and
matrices of alternative health care finance and shared how disease foundations,
private donors, and nonprofit organizations became huge contributors for the
development of new therapies.
The forum was hosted by W Medical Strategy
Group and sponsored by It’s a Wig, FTI Consulting, and Green Alley. The next
New York Health Forum will be held in June. For further information about the
NYHF and for more photos, please visit www.newyorkhealthforum.net
Rachel Hong, RN
Agenda Coordinator
New York Health Forum
Rachel is editorial staff of WKMJ and agenda
coordinator of New York Health Forum. She is associate of Business Operations at
W Medical Strategy Group.
Yisun Yuk
Manager,
Business Operations W Medical
Strategy Group
Yisun is manager of Business
Operations at W Medical Strategy Group. She also is an editorial staff of WKMJ
and organizing executive of New York Health Forum.